Skip to main content
Clinical Trials/DRKS00013891
DRKS00013891
Completed
未知

Detection of intratumoral heterogeneity of breast cancer by multiparametric imaging using 18F-FDG-PET/MRT - GK-PET/MR_Tü-018

niversitätsklinikum Tübingen, Radiologiesche Klinik, Interv. u. Diagnostische Radiologie0 sites61 target enrollmentJanuary 22, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
primary breasttumor
Sponsor
niversitätsklinikum Tübingen, Radiologiesche Klinik, Interv. u. Diagnostische Radiologie
Enrollment
61
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 22, 2018
End Date
April 18, 2020
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversitätsklinikum Tübingen, Radiologiesche Klinik, Interv. u. Diagnostische Radiologie

Eligibility Criteria

Inclusion Criteria

  • women, age \=18 years,
  • proven primary breast carcinoma (by punch biopsy, \=14G) (subtypes luminal A, B, and HER\-/neu\-pos. basal\-like tumors)
  • tumor size \=10 mm,
  • clinical indication for primary surgery,
  • contraception,
  • informed consent for clinical study,
  • informed consent for useage of biomaterial

Exclusion Criteria

  • clinical indication for neo\-adjuvant therapy,
  • precnancy/breast feeding women,
  • contra\-indication for MRT such as metallic implants, pacemaker etc., clip\-marking of breast tumor,
  • contra\-indication for MR\-contrast agent Gadolinium,
  • claustrophobia, high sensitivity to temperatur sensitivity, high sensitivity to noise,
  • limited contractual capability,
  • exclusion criteria due to StrlSchV such as job\-related radiation exposure \>15mSv/a

Outcomes

Primary Outcomes

Not specified

Similar Trials